Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Aranzazu Jauregui-Amezaga, Michael Somers, Heiko De Schepper & Elisabeth Macken. (2017) Next generation of biologics for the treatment of Crohn’s disease: an evidence-based review on ustekinumab. Clinical and Experimental Gastroenterology 10, pages 293-301.
Read now
Read now
Xiujuan Wu, Juan Wang, Kangding Liu, Jie Zhu & Hong-Liang Zhang. (2016) Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?. Expert Opinion on Therapeutic Targets 20:2, pages 209-222.
Read now
Read now
Emilie Duvallet, Luca Semerano, Eric Assier, Géraldine Falgarone & Marie-Christophe Boissier. (2011) Interleukin-23: A key cytokine in inflammatory diseases. Annals of Medicine 43:7, pages 503-511.
Read now
Read now
Nora Koutruba, Jason Emer & Mark Lebwohl. (2010) Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis. Therapeutics and Clinical Risk Management 6, pages 123-141.
Read now
Read now
Adam W. Clarke, Lynn Poulton, Hoi Yi Wai, Stuart A. Walker, Shanti David Victor, Teresa Domagala, Dragana Mraovic, Danyal Butt, Nina Shewmaker, Phil A. Jennings & Anthony G. Doyle. (2010) A novel class of anti-IL-12p40 antibodies. mAbs 2:5, pages 539-549.
Read now
Read now
Mario M D'Elios, Gianfranco Del Prete & Amedeo Amedei. (2010) Targeting IL-23 in human diseases. Expert Opinion on Therapeutic Targets 14:7, pages 759-774.
Read now
Read now
Mathias Buttmann. (2010) Treating multiple sclerosis with monoclonal antibodies: a 2010 update. Expert Review of Neurotherapeutics 10:5, pages 791-809.
Read now
Read now
Oya Cingoz. (2009) Ustekinumab. mAbs 1:3, pages 216-221.
Read now
Read now
Articles from other publishers (53)
Anna Hau-Yee Kong, Aston Jiaxi Wu, Olivia Ka-Yi Ho, Maggie Ming-Ki Leung, Alexis Shiying Huang, Yuanyuan Yu, Ge Zhang, Aiping Lyu, Min Li & King-Ho Cheung. (2023) Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges. International Journal of Molecular Sciences 24:14, pages 11780.
Crossref
Crossref
Jean-Guillaume Letarouilly, Patrick Vermersch & René-Marc Flipo. (2023) Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis. Rheumatology 62:7, pages 2352-2359.
Crossref
Crossref
A. Quesada-Simó, A. Garrido-Marín, P. Nos & S. Gil-Perotín. (2023) Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review. Frontiers in Pharmacology 14.
Crossref
Crossref
Franz Felix Konen, Nora Möhn, Torsten Witte, Matthias Schefzyk, Miriam Wiestler, Svjetlana Lovric, Karsten Hufendiek, Philipp Schwenkenbecher, Kurt-Wolfram Sühs, Manuel A. Friese, Luisa Klotz, Refik Pul, Marc Pawlitzki, David Hagin, Christoph Kleinschnitz, Sven G. Meuth & Thomas Skripuletz. (2023) Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmunity Reviews 22:5, pages 103312.
Crossref
Crossref
Fatma Zehra Okus, Zehra Busra Azizoglu, Halit Canatan & Ahmet Eken. (2022) S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo. International Immunopharmacology 107, pages 108665.
Crossref
Crossref
Mai Fujiwara, Radhika Raheja, Lucien P. Garo, Amrendra K. Ajay, Ryoko Kadowaki-Saga, Sukrut H. Karandikar, Galina Gabriely, Rajesh Krishnan, Vanessa Beynon, Anu Paul, Amee Patel, Shrishti Saxena, Dan Hu, Brian C. Healy, Tanuja Chitnis, Roopali Gandhi, Howard L. Weiner & Gopal Murugaiyan. (2022) microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance. Journal of Clinical Investigation 132:10.
Crossref
Crossref
Despoina T. Florou, Athanasios Mavropoulos, Efthymios Dardiotis, Vana Tsimourtou, Vasileios Siokas, Athina-Maria Aloizou, Christos Liaskos, Christina Tsigalou, Christina Katsiari, Lazaros I. Sakkas, Georgios Hadjigeorgiou & Dimitrios P. Bogdanos. (2021) Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis. Frontiers in Immunology 12.
Crossref
Crossref
Hisashi Kawashima, Shinichiro Morichi, Gaku Yamanaka, Hiroo Terashi & Yasuyo Kashiwagi. (2021) Correlation between Cerebrospinal Fluid IL-12 Levels and Severity of Encephalopathy in Children. Journal of Clinical Medicine 10:17, pages 3873.
Crossref
Crossref
Mir Hadi Jazayeri, Khadijeh barzaman, Reza Nedaeinia, Tayebe Aghaie & Morteza Motallebnezhad. (2020) Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease?. Autoimmunity Highlights 11:1.
Crossref
Crossref
Igal Ifergan & Stephen D. Miller. (2020) Potential for Targeting Myeloid Cells in Controlling CNS Inflammation. Frontiers in Immunology 11.
Crossref
Crossref
Susanta MondalMadhuchhanda KunduMalabendu JanaAvik RoySuresh B. RangasamyKhushbu K. ModiJennillee WallaceYasmeen A. Albalawi, Roumen Balabanov & Kalipada Pahan. (2020) IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE. Proceedings of the National Academy of Sciences 117:35, pages 21557-21567.
Crossref
Crossref
Rodica Balasa, Laura Barcutean, Adrian Balasa, Anca Motataianu, Corina Roman-Filip & Doina Manu. (2020) The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis. Human Immunology 81:5, pages 237-243.
Crossref
Crossref
Bing Wu & Yisong Wan. (2020) Molecular control of pathogenic Th17 cells in autoimmune diseases. International Immunopharmacology 80, pages 106187.
Crossref
Crossref
Yoshiki Nakamura, Keiko Igaki, Keiko Uga, Akira Shibata, Hirofumi Yamauchi, Masashi Yamasaki & Noboru Tsuchimori. (2019) Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model. Journal of Neuroimmunology 335, pages 577016.
Crossref
Crossref
T. van der Heijden, I. Bot & J. Kuiper. (2019) The IL-12 cytokine family in cardiovascular diseases. Cytokine 122, pages 154188.
Crossref
Crossref
Lyuba Miteva, Anastasiya Trenova, Georgi Slavov & Spaska Stanilova. (2018) IL12B gene polymorphisms have sex-specific effects in relapsing–remitting multiple sclerosis. Acta Neurologica Belgica 119:1, pages 83-93.
Crossref
Crossref
Kathryn L. Pepple & Phoebe Lin. (2018) Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis. Ophthalmology 125:12, pages 1977-1983.
Crossref
Crossref
Kexin Wang, Feng Song, Alejandro Fernandez-Escobar, Gang Luo, Jun-Hui Wang & Yu Sun. (2018) The Properties of Cytokines in Multiple Sclerosis: Pros and Cons. The American Journal of the Medical Sciences 356:6, pages 552-560.
Crossref
Crossref
V. S. Gogoleva, K. -S. N. Atretkhany, M. S. Drutskaya, I. A. Mufazalov, A. A. Kruglov & S. A. Nedospasov. (2018) Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis. Biochemistry (Moscow) 83:9, pages 1089-1103.
Crossref
Crossref
Danielle Cristina Zimmermann-Franco, Bruna Esteves, Leticia Moroni Lacerda, Isabela de Oliveira Souza, Juliana Alves dos Santos, Nícolas de Castro Campos Pinto, Elita Scio, Adilson David da Silva & Gilson Costa Macedo. (2018) In vitro and in vivo anti-inflammatory properties of imine resveratrol analogues. Bioorganic & Medicinal Chemistry 26:17, pages 4898-4906.
Crossref
Crossref
Belinda J. Kaskow & Clare Baecher-Allan. (2018) Effector T Cells in Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 8:4, pages a029025.
Crossref
Crossref
Michael Hiltensperger & Thomas Korn. (2018) The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 8:1, pages a029637.
Crossref
Crossref
Amy E. Lovett-Racke & Michael K. Racke. 2018. Neuroinflammation. Neuroinflammation
115
139
.
Igal Ifergan, Todd S. Davidson, Hania Kebir, Dan Xu, Daphne Palacios-Macapagal, Jennifer Cann, Jane M. Rodgers, Zoe N. Hunter, Camille L. Pittet, Sara Beddow, Clare A. Jones, Alexandre Prat, Matthew A. Sleeman & Stephen D. Miller. (2017) Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. Journal of Autoimmunity 84, pages 1-11.
Crossref
Crossref
Paul R. Mangan, Linhui Julie Su, Victoria Jenny, Andrea L. Tatum, Caryn Picarillo, Stacey Skala, Noah Ditto, Zheng Lin, XiaoXia Yang, Pete Z. Cotter, David J. Shuster, Yunling Song, Virna Borowski, Rochelle L. Thomas, Elizabeth M. Heimrich, Brigitte Devaux, Ruchira Das Gupta, Irvith Carvajal, Kim W. McIntyre, Jenny Xie, Qihong Zhao, Mary Struthers & Luisa M. Salter-Cid. (2015) Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity. Journal of Pharmacology and Experimental Therapeutics 354:2, pages 152-165.
Crossref
Crossref
Claudio Procaccini, Veronica De Rosa, Valentina Pucino, Luigi Formisano & Giuseppe Matarese. (2015) Animal models of Multiple Sclerosis. European Journal of Pharmacology 759, pages 182-191.
Crossref
Crossref
John S. Tokarski, Adriana Zupa-Fernandez, Jeffrey A. Tredup, Kristen Pike, ChiehYing Chang, Dianlin Xie, Lihong Cheng, Donna Pedicord, Jodi Muckelbauer, Stephen R. Johnson, Sophie Wu, Suzanne C. Edavettal, Yang Hong, Mark R. Witmer, Lisa L. Elkin, Yuval Blat, William J. Pitts, David S. Weinstein & James R. Burke. (2015) Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain. Journal of Biological Chemistry 290:17, pages 11061-11074.
Crossref
Crossref
M K Ottow, E J Klaver, T C T M van der Pouw Kraan, P D Heijnen, L C Laan, H Kringel, D Y S Vogel, C D Dijkstra, G Kooij & I van Die. (2014) The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages. Genes & Immunity 15:7, pages 477-486.
Crossref
Crossref
Wei Guo, Cheng Luo, Chen Wang, Yu heng Wang, Xin Wang, Xiang dong Gao & Wen Bing Yao. (2014) Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region. The International Journal of Biochemistry & Cell Biology 55, pages 304-310.
Crossref
Crossref
Oya Cingoz, Stefan Dübel & Janice M. Reichert. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
2069
2086
.
Michael K. RackeYuhong YangAmy E. Lovett-Racke. (2014) Is T-bet a Potential Therapeutic Target in Multiple Sclerosis?. Journal of Interferon & Cytokine Research 34:8, pages 623-632.
Crossref
Crossref
Masaaki Niino, Toshiyuki Fukazawa, Yusei Miyazaki, Eri Takahashi, Naoya Minami, Itaru Amino, Naoto Fujiki, Shizuki Doi & Seiji Kikuchi. (2014) Suppression of IL-10 production by calcitriol in patients with multiple sclerosis. Journal of Neuroimmunology 270:1-2, pages 86-94.
Crossref
Crossref
Manuel Comabella & Xavier Montalban. (2014) Body fluid biomarkers in multiple sclerosis. The Lancet Neurology 13:1, pages 113-126.
Crossref
Crossref
Genaro G. Ortiz, Fermín P. Pacheco-Moisés, Oscar K. Bitzer-Quintero, Ana C. Ramírez-Anguiano, Luis J. Flores-Alvarado, Viridiana Ramírez-Ramírez, Miguel A. Macias-Islas & Erandis D. Torres-Sánchez. (2013) Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach. Clinical and Developmental Immunology 2013, pages 1-14.
Crossref
Crossref
Marina M. Zafranskaya, Darya B. Nizheharodova, Mariya Yu. Yurkevich, Natallia V. Lamouskaya, Yana M. Motuzova, Svetlana S. Bagatka, Halina I. Ivanchik & Alexander S. Fedulov. (2013) In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients. Immunology Letters 149:1-2, pages 9-18.
Crossref
Crossref
Ken Flanagan, Kent Fitzgerald, Jeanne Baker, Karin Regnstrom, Shyra Gardai, Frederique Bard, Simonetta Mocci, Pui Seto, Monica You, Catherine Larochelle, Alexandre Prat, Samuel Chow, Lauri Li, Chris Vandevert, Wagner Zago, Carlos Lorenzana, Christopher Nishioka, Jennifer Hoffman, Raquel Botelho, Christopher Willits, Kevin Tanaka, Jennifer Johnston & Ted Yednock. (2012) Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS. PLoS ONE 7:7, pages e40443.
Crossref
Crossref
Kim A. Papp, Joel DeKoven, Laurie Parsons, Syed Pirzada, Michael Robern, Lynne Robertson & Jerry K.L. Tan. (2012) Biologic Therapy in Psoriasis: Perspectives on Associated Risks and Patient Management. Journal of Cutaneous Medicine and Surgery 16:3, pages 153-168.
Crossref
Crossref
Henrik Gensicke, David Leppert, Özgür Yaldizli, Raija L.P. Lindberg, Matthias Mehling, Ludwig Kappos & Jens Kuhle. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs 26:1, pages 11-37.
Crossref
Crossref
Andrey A. Kruglov, Vicky Lampropoulou, Simon Fillatreau & Sergei A. Nedospasov. (2011) Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells. The Journal of Immunology 187:11, pages 5660-5670.
Crossref
Crossref
Ari Waisman. (2011) T helper cell populations: As flexible as the skin?. European Journal of Immunology 41:9, pages 2539-2543.
Crossref
Crossref
Paresh Thakker, Suzana Marusic, Nancy L. Stedman, Katherine L. Lee, John C. McKew, Andrew Wood, Samuel J. Goldman, Michael W. Leach, Mary Collins, Vijay K. Kuchroo, Stanley F. Wolf, James D. Clark & Mina Hassan-Zahraee. (2011) Cytosolic Phospholipase A2α Blockade Abrogates Disease during the Tissue-Damage Effector Phase of Experimental Autoimmune Encephalomyelitis by Its Action on APCs. The Journal of Immunology 187:4, pages 1986-1997.
Crossref
Crossref
Andrew R Pachner. (2011) Experimental models of multiple sclerosis. Current Opinion in Neurology 24:3, pages 291-299.
Crossref
Crossref
Timothy L VollmerDaniel R WynnM Shamsul AlamJoaquin Valdes. (2010) A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing–remitting or secondary progressive multiple sclerosis. Multiple Sclerosis Journal 17:2, pages 181-191.
Crossref
Crossref
Henry McFarland. (2011) The importance of clinical trials in unraveling the mysteries of multiple sclerosis. Journal of Neuroimmunology 231:1-2, pages 3-6.
Crossref
Crossref
Yuhong Yang, Amy E. Lovett-Racke & Michael K. Racke. 2011. Neuroinflammation. Neuroinflammation
107
136
.
J M Fletcher, S J Lalor, C M Sweeney, N Tubridy & K H G Mills. (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 162:1, pages 1-11.
Crossref
Crossref
Helena Batoulis, Klaus Addicks & Stefanie Kuerten. (2010) Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm. Annals of Anatomy - Anatomischer Anzeiger 192:4, pages 179-193.
Crossref
Crossref
JS Alexander, MK Harris, SR Wells, G. Mills, K. Chalamidas, VC Ganta, J. McGee, MH Jennings, E. Gonzalez-Toledo & A. Minagar. (2010) Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b. Multiple Sclerosis Journal 16:7, pages 801-809.
Crossref
Crossref
Laura Codarri, Adriano Fontana & Burkhard Becher. (2010) Cytokine networks in multiple sclerosis: lost in translation. Current Opinion in Neurology 23:3, pages 205-211.
Crossref
Crossref
Tobias D. Merson, Michele D. Binder & Trevor J. Kilpatrick. (2010) Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS. NeuroMolecular Medicine 12:2, pages 99-132.
Crossref
Crossref
Yolanda S. Kap, Jon D. Laman & Bert A. ‘t Hart. (2009) Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development. Journal of Neuroimmune Pharmacology 5:2, pages 220-230.
Crossref
Crossref
Lawrence Steinman. (2009) Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nature Immunology 11:1, pages 41-44.
Crossref
Crossref
Michael Elliott, Jacqueline Benson, Marion Blank, Carrie Brodmerkel, Daniel Baker, Kristin Ruley Sharples & Philippe Szapary. (2009) Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases. Annals of the New York Academy of Sciences 1182:1, pages 97-110.
Crossref
Crossref